Recent Finacing
Recent Raise
Pluristem develops placenta-derived off-the-shelf PLX cell therapies grown via proprietary GMP manufacturing, conducts late-stage clinical trials for inflammatory, ischemic and trauma indications, and provided COVID-19 compassionate-use treatments.
